WVE: Wave Life Sciences Ltd.
Performance
WVE -55.73%
Watchlist
Select an item
Summary
WVE at a glance
WVE returned -55.73% over the past year and -5.82% a year over five years. Its worst drop in that year was -85.50%, smaller than 0% of stocks on Redstone, and its Sharpe ratio of 0.06 beats 29% of stocks on Redstone. It pays no dividends.
Current Drawdown
-83.67%
Rolling Volatility
69.63%
Actions
Metrics
Risk Indicators
Alpha-3.08%
Beta1.35x
Sharpe0.06
Sortino0.15
Omega1.02
Calmar-0.65
Martin0.17
Profile
About WVE
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $686M
- Listed
- Nov 2015
- Employees
- 317
- Headquarters
- Cambridge, MA
- Website
- wavelifesciences.com
Comparisons